Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 27, 2003
[Clinical implications of trastuzumab]Toshiaki Saeki, Shigemitsu Takashima
Breast Cancer (Tokyo, Japan)|November 20, 2004
Capecitabine plus docetaxel combination chemotherapy for metastatic breast cancerToshiaki Saeki, Shigemitsu Takashima
Surgery Today|October 30, 2008
Esophagectomy via left thoracotomy for esophageal cancer with situs inversus totalis: report of a caseTakahiro Mimae, Isao Nozaki, Akira Kurita, et al.
Breast Cancer Research and Treatment|September 11, 2002
Prognostic value of thermographical findings in patients with primary breast cancerShozo Ohsumi, Shigemitsu Takashima, Kenjiro Aogi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 19, 2002
Breast-conserving therapy consisting of wide excision, axillary dissection, and radiotherapy for early-stage breast cancer: the experience of the National Shikoku Cancer CenterShozo Ohsumi, Shigemitsu Takashima, Toshiaki Saeki, et al.
The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai Zasshi|February 4, 2003
Unsuspected primary pulmonary malignant lymphomaHiroyuki Tao, Masao Nakata, Hideyuki Saeki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 10, 2004
[Local administration of adriamycin (ADM) for malignant pleural effusion and pericardiac effusion in breast cancer]Shinsuke Saisho, Toshiaki Saeki, Shigemitsu Takashima, et al.
Acta Medica Okayama|May 2, 2007
Unusual abscesses associated with colon cancer: report of three casesAtsushi Okita, Yoshiro Kubo, Minoru Tanada, et al.
Breast Cancer (Tokyo, Japan)|January 25, 2007
Immunohistochemical expression of hormone receptors and the histological characteristics of biochemically hormone receptor negative breast cancersRieko Nishimura, Toshiaki Saeki, Shozo Ohsumi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 14, 2006
[Retrospective evaluation of the safety of pamidronate administration at the dose of 90 mg/day/month in Japanese breast cancer patients with bone metastasis]Kenjiro Aogi, Atsushi Okita, Naruto Taira, et al.
Pageof 10